▶ 調査レポート

世界のアダリムマブ市場2019

• 英文タイトル:Global Adalimumab Sales Market Report 2019
• レポートコード:QYR9M0073
• 出版社/出版日:QYResearch / 2019年4月30日
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥424,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥848,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、アダリムマブの世界市場について調査・分析し、アダリムマブのメーカー別販売量、市場シェア分析、種類別販売分析(アダリムマブ、アダリムマブのバイオシミラー)、用途別販売分析(大人、子供)、地域別販売分析(米国、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・アダリムマブ市場概要
・アダリムマブのメーカー別販売量・メーカー別シェア
・アダリムマブの種類別販売量(アダリムマブ、アダリムマブのバイオシミラー)
・アダリムマブの用途別販売量(大人、子供)
・アダリムマブの地域別販売量・市場シェア
・アダリムマブの米国市場規模(2014年-2019年)
・アダリムマブのヨーロッパ市場規模(2014年-2019年)
・アダリムマブの中国市場規模(2014年-2019年)
・アダリムマブの日本市場規模(2014年-2019年)
・アダリムマブの東南アジア市場規模(2014年-2019年)
・アダリムマブのインド市場規模(2014年-2019年)
・アダリムマブメーカー分析(企業概要、製品概要、販売量、売上、価格等)
・アダリムマブのコスト分析
・アダリムマブ販売チャネル、流通業者、顧客
・アダリムマブの世界市場動向・機会・成長要因・課題
・アダリムマブの種類別世界市場予測(アダリムマブ、アダリムマブのバイオシミラー)
・アダリムマブの用途別世界市場予測(大人、子供)
・アダリムマブの米国市場予測(2019年-2025年)
・アダリムマブのヨーロッパ市場予測(2019年-2025年)
・アダリムマブの中国市場予測(2019年-2025年)
・アダリムマブの日本市場予測(2019年-2025年)
・アダリムマブの東南アジア市場予測(2019年-2025年)
・アダリムマブのインド市場予測(2019年-2025年)
...

Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis.
The global Adalimumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Adalimumab market status and forecast, categorizes the global Adalimumab market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
AbbVie
Amgen
Sandoz
Boehringer Ingelheim
Mylan
Biogen

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Adalimumab
Adalimumab Biosimilar

Segment by Application
Adults
Children

レポート目次

Table of Contents

Global Adalimumab Sales Market Report 2019
1 Adalimumab Market Overview
1.1 AdalimumabProduct Overview
1.2 Adalimumab Segment by Type
1.2.1 Global Adalimumab Sales Comparison by Types (2014-2025)
1.2.2 Adalimumab
1.2.3 Adalimumab Biosimilar
1.3 Adalimumab Segment by Application
1.3.1 Global Adalimumab Sales Comparison by Application (2014-2025)
1.3.1 Adults
1.3.2 Children
1.4 Adalimumab Market by Region
1.4.1 Global Adalimumab Revenue Comparison by Region (2014-2025)
1.4.2 United States Adalimumab Status and Prospect (2014-2025)
1.4.3 Europe Adalimumab Status and Prospect (2014-2025)
1.4.4 China Adalimumab Status and Prospect (2014-2025)
1.4.5 Japan Adalimumab Status and Prospect (2014-2025)
1.4.6 Southeast Asia Adalimumab Status and Prospect (2014-2025)
1.4.7 India Adalimumab Status and Prospect (2014-2025)
1.5 Global Adalimumab Sales and Revenue (2014-2025)
1.5.1 Global Adalimumab Sales and Growth Rate (2014-2025)
1.5.2 Global Adalimumab Revenue and Growth Rate (2014-2025)

2 Adalimumab by Company, Region, Type and Application
2.1 Global Adalimumab Market Competition by Companies
2.1.1 Global Adalimumab Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Adalimumab Revenue Market Share by Company (2014-2019)
2.2 Global Adalimumab Sales and Revenue by Region
2.2.1 Global Adalimumab Sales Market Share by Region (2014-2019)
2.2.2 Global Adalimumab Revenue Market Share by Region (2014-2019)
2.3 Global Adalimumab Sales and Revenue by Type
2.3.1 Global Adalimumab Sales Market Share by Type (2014-2019)
2.3.2 Global Adalimumab Revenue Market Share by Type (2014-2019)
2.4 Global Adalimumab Sales by Application

3 United States Adalimumab Sales, Revenue and Price
3.1 United States Adalimumab Sales and Revenue (2014-2019)
3.1.1 United States Adalimumab Sales Growth Rate (2014-2019)
3.1.2 United States Adalimumab Revenue Growth Rate (2014-2019)
3.1.3 United States Adalimumab Price Trend (2014-2019)
3.2 United States Adalimumab Sales Market Share by Company
3.3 United States Adalimumab Sales Market Share by Type
3.4 United States Adalimumab Sales Market Share by Application

4 Europe Adalimumab Sales, Revenue and Price
4.1 Europe Adalimumab Sales and Value (2014-2019)
4.1.1 Europe Adalimumab Sales Growth Rate (2014-2019)
4.1.2 Europe Adalimumab Revenue Growth Rate (2014-2019)
4.1.3 Europe Adalimumab Price Trend (2014-2019)
4.2 Europe Adalimumab Sales Market Share by Company
4.3 Europe Adalimumab Sales Market Share by Type
4.4 Europe Adalimumab Sales Market Share by Application

5 China Adalimumab Sales, Revenue and Price
5.1 China Adalimumab Sales and Revenue (2014-2019)
5.1.1 China Adalimumab Sales Growth Rate (2014-2019)
5.1.2 China Adalimumab Revenue Growth Rate (2014-2019)
5.1.3 China Adalimumab Price Trend (2014-2019)
5.2 China Adalimumab Sales Market Share by Company
5.3 China Adalimumab Sales Market Share by Type
5.4 China Adalimumab Sales Market Share by Application

6 Japan Adalimumab Sales, Revenue and Price
6.1 Japan Adalimumab Sales and Value (2014-2019)
6.1.1 Japan Adalimumab Sales Growth Rate (2014-2019)
6.1.2 Japan Adalimumab Revenue Growth Rate (2014-2019)
6.1.3 Japan Adalimumab Price Trend (2014-2019)
6.2 Japan Adalimumab Sales Market Share by Company
6.3 Japan Adalimumab Sales Market Share by Type
6.4 Japan Adalimumab Sales Market Share by Application

7 Southeast Asia Adalimumab Sales, Revenue and Price
7.1 Southeast Asia Adalimumab Sales and Value (2014-2019)
7.1.1 Southeast Asia Adalimumab Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Adalimumab Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Adalimumab Price Trend (2014-2019)
7.2 Southeast Asia Adalimumab Sales Market Share by Company
7.3 Southeast Asia Adalimumab Sales Market Share by Type
7.4 Southeast Asia Adalimumab Sales Market Share by Application

8 India Adalimumab Sales, Revenue and Price
8.1 India Adalimumab Sales and Value (2014-2019)
8.1.1 India Adalimumab Sales Growth Rate (2014-2019)
8.1.2 India Adalimumab Revenue Growth Rate (2014-2019)
8.1.3 India Adalimumab Price Trend (2014-2019)
8.2 India Adalimumab Sales Market Share by Company
8.3 India Adalimumab Sales Market Share by Type
8.4 India Adalimumab Sales Market Share by Application

9 Company Profiles and Key Figures in Adalimumab Business
9.1 AbbVie
9.1.1 AbbVie Adalimumab Production Sites and Area Served
9.1.2 Adalimumab Specification and Application
9.1.3 AbbVie Adalimumab Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Amgen
9.2.1 Amgen Adalimumab Production Sites and Area Served
9.2.2 Adalimumab Specification and Application
9.2.3 Amgen Adalimumab Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Sandoz
9.3.1 Sandoz Adalimumab Production Sites and Area Served
9.3.2 Adalimumab Specification and Application
9.3.3 Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Boehringer Ingelheim
9.4.1 Boehringer Ingelheim Adalimumab Production Sites and Area Served
9.4.2 Adalimumab Specification and Application
9.4.3 Boehringer Ingelheim Adalimumab Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Mylan
9.5.1 Mylan Adalimumab Production Sites and Area Served
9.5.2 Adalimumab Specification and Application
9.5.3 Mylan Adalimumab Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Biogen
9.6.1 Biogen Adalimumab Production Sites and Area Served
9.6.2 Adalimumab Specification and Application
9.6.3 Biogen Adalimumab Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served

10 Adalimumab Maufacturing Cost Analysis
10.1 Adalimumab Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Adalimumab
10.4 Adalimumab Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Adalimumab Distributors List
11.3 Adalimumab Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Adalimumab Market Forecast
13.1 Global Adalimumab Sales, Revenue and Price Forecast
13.1.1 Global Adalimumab Sales Growth Forecast (2019-2025)
13.1.2 Global Adalimumab Revenue Growth Forecast (2019-2025)
13.1.3 Global Adalimumab Price Trend Forecast (2019-2025)
13.2 Global Adalimumab Forecast by Region
13.2.1 Global Adalimumab Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Adalimumab Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Adalimumab Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Adalimumab Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Adalimumab Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Adalimumab Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Adalimumab Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Adalimumab Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Adalimumab Forecast by Type
13.3.1 Global Adalimumab Sales Forecast by Type (2019-2025)
13.3.2 Global Adalimumab Revenue Forecast by Type (2019-2025)
13.3.3 Global Adalimumab Price Forecast by Type (2019-2025)
13.4 Global Adalimumab Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Adalimumab Sales (K Units) and Value (Revenue: Million US$)
Market Breakdown by Type: Adalimumab Sales (K Units) and Revenue (Million US$)
Market Breakdown by Application: Adalimumab Sales (Feb)
Figure Adalimumab Product Picture
Table Global Adalimumab Sales (K Units) Growth Rate by Types (2014-2025)
Figure Global Adalimumab Sales Market Share by Types in 2018
Figure Adalimumab Product Picture
Figure Adalimumab Biosimilar Product Picture
Table Global Adalimumab Sales (K Units) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Adalimumab by Application in 2018
Figure Adults Examples
Figure Children Examples
Table Global Market Adalimumab Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Adalimumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Adalimumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Adalimumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Adalimumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Adalimumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Adalimumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Adalimumab Sales (K Units) Growth Rate (2014-2025)
Figure Global Adalimumab Revenue (Million USD) Growth Rate (2014-2025)
Table Global Adalimumab Sales (K Units) of Key Companies (2014-2019)
Figure Global Adalimumab Sales by Company in 2018
Table Global Adalimumab Sales Share by Company (2014-2019)
Figure Global Adalimumab Sales Share by Company in 2018
Table Global Adalimumab Revenue (Million USD) by Company (2014-2019)
Figure Global Adalimumab Revenue (Million USD) by Company in 2018
Table Global Adalimumab Revenue Share by Company (2014-2019)
Figure Global Adalimumab Revenue Share by Company in 2018
Table Global Adalimumab Sales (K Units) Market Share by Region (2014-2019)
Table Global Adalimumab Sales Share by Region (2014-2019)
Figure Global Adalimumab Sales Share by Region in 2018
Table Global Adalimumab Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Adalimumab Revenue Share by Region (2014-2019)
Figure Global Adalimumab Revenue Market Share by Region In 2018
Table Global Adalimumab Sales (K Units) by Type (2014-2019)
Table Global Adalimumab Sales Share by Type (2014-2019)
Figure Global Adalimumab Sales Growth Rate by Type in 2018
Table Global Adalimumab Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Adalimumab Revenue Share by Type (2014-2019)
Figure Global Adalimumab Revenue Growth Rate by Type in 2018
Table Global Adalimumab Sales Market Share by Application (2014-2019)
Table Global Adalimumab Sales Share by Application (2014-2019)
Figure Global Adalimumab Sales Market Share by Application in 2018
Figure United States Adalimumab Sales (K Units) and Growth Rate (2014-2019)
Figure United States Adalimumab Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Adalimumab Price (USD/Unit) Trend (2014-2019)
Table United States Adalimumab Sales (K Units) by Company (2014-2019)
Table United States Adalimumab Sales Market Share by Company (2014-2019)
Figure United States Adalimumab Sales Market Share by Company in 2018
Table United States Adalimumab Sales (K Units) by Type (2014-2019)
Table United States Adalimumab Sales Market Share by Type (2014-2019)
Figure United States Adalimumab Sales Market Share by Type in 2018
Table United States Adalimumab Sales (K Units) by Application (2014-2019)
Table United States Adalimumab Sales Market Share by Application (2014-2019)
Figure United States Adalimumab Sales Market Share by Application in 2018
Figure Europe Adalimumab Sales (K Units) and Growth Rate (2014-2019)
Figure Europe Adalimumab Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Adalimumab Price (USD/Unit) Trend (2014-2019)
Table Europe Adalimumab Sales (K Units) by Company (2014-2019)
Table Europe Adalimumab Sales Market Share by Company (2014-2019)
Figure Europe Adalimumab Sales Market Share by Company in 2018
Table Europe Adalimumab Sales (K Units) by Type (2014-2019)
Table Europe Adalimumab Sales Market Share by Type (2014-2019)
Figure Europe Adalimumab Sales Market Share by Type in 2018
Table Europe Adalimumab Sales (K Units) by Application (2014-2019)
Table Europe Adalimumab Sales Market Share by Application (2014-2019)
Figure Europe Adalimumab Sales Market Share by Application in 2018
Figure China Adalimumab Sales (K Units) and Growth Rate (2014-2019)
Figure China Adalimumab Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Adalimumab Price (USD/Unit) Trend (2014-2019)
Table China Adalimumab Sales (K Units) by Company (2014-2019)
Table China Adalimumab Sales Market Share by Company (2014-2019)
Figure China Adalimumab Sales Market Share by Company in 2018
Table China Adalimumab Sales (K Units) by Type (2014-2019)
Table China Adalimumab Sales Market Share by Type (2014-2019)
Figure China Adalimumab Sales Market Share by Type in 2018
Table China Adalimumab Sales (K Units) by Application (2014-2019)
Table China Adalimumab Sales Market Share by Application (2014-2019)
Figure China Adalimumab Sales Market Share by Application in 2018
Figure Japan Adalimumab Sales (K Units) and Growth Rate (2014-2019)
Figure Japan Adalimumab Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Adalimumab Price (USD/Unit) Trend (2014-2019)
Table Japan Adalimumab Sales (K Units) by Company (2014-2019)
Table Japan Adalimumab Sales Market Share by Company (2014-2019)
Figure Japan Adalimumab Sales Market Share by Company in 2018
Table Japan Adalimumab Sales (K Units) by Type (2014-2019)
Table Japan Adalimumab Sales Market Share by Type (2014-2019)
Figure Japan Adalimumab Sales Market Share by Type in 2018
Table Japan Adalimumab Sales (K Units) by Application (2014-2019)
Table Japan Adalimumab Sales Market Share by Application (2014-2019)
Figure Japan Adalimumab Sales Market Share by Application in 2018
Figure Southeast Asia Adalimumab Sales (K Units) and Growth Rate (2014-2019)
Figure Southeast Asia Adalimumab Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Adalimumab Price (USD/Unit) Trend (2014-2019)
Table Southeast Asia Adalimumab Sales (K Units) by Company (2014-2019)
Table Southeast Asia Adalimumab Sales Market Share by Company (2014-2019)
Figure Southeast Asia Adalimumab Sales Market Share by Company in 2018
Table Southeast Asia Adalimumab Sales (K Units) by Type (2014-2019)
Table Southeast Asia Adalimumab Sales Market Share by Type (2014-2019)
Figure Southeast Asia Adalimumab Sales Market Share by Type in 2018
Table Southeast Asia Adalimumab Sales (K Units) by Application (2014-2019)
Table Southeast Asia Adalimumab Sales Market Share by Application (2014-2019)
Figure Southeast Asia Adalimumab Sales Market Share by Application in 2018
Figure India Adalimumab Sales (K Units) and Growth Rate (2014-2019)
Figure India Adalimumab Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Adalimumab Price (USD/Unit) Trend (2014-2019)
Table India Adalimumab Sales (K Units) by Company (2014-2019)
Table India Adalimumab Sales Market Share by Company (2014-2019)
Figure India Adalimumab Sales Market Share by Company in 2018
Table India Adalimumab Sales (K Units) by Type (2014-2019)
Table India Adalimumab Sales Market Share by Type (2014-2019)
Figure India Adalimumab Sales Market Share by Type in 2018
Table India Adalimumab Sales (K Units) by Application (2014-2019)
Table India Adalimumab Sales Market Share by Application (2014-2019)
Figure India Adalimumab Sales Market Share by Application in 2018
Table AbbVie Adalimumab Production Sites and Area Served
Table AbbVie Adalimumab Specification and Application
Table AbbVie Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure AbbVie Adalimumab Sales Growth Rate (2014-2019)
Figure AbbVie Adalimumab Revenue Share in International Market (2014-2019)
Figure AbbVie Adalimumab Main Business and Markets Served
Table Amgen Adalimumab Production Sites and Area Served
Table Amgen Adalimumab Specification and Application
Table Amgen Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Amgen Adalimumab Sales Growth Rate (2014-2019)
Figure Amgen Adalimumab Revenue Share in International Market (2014-2019)
Figure Amgen Adalimumab Main Business and Markets Served
Table Sandoz Adalimumab Production Sites and Area Served
Table Sandoz Adalimumab Specification and Application
Table Sandoz Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Sandoz Adalimumab Sales Growth Rate (2014-2019)
Figure Sandoz Adalimumab Revenue Share in International Market (2014-2019)
Figure Sandoz Adalimumab Main Business and Markets Served
Table Boehringer Ingelheim Adalimumab Production Sites and Area Served
Table Boehringer Ingelheim Adalimumab Specification and Application
Table Boehringer Ingelheim Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Boehringer Ingelheim Adalimumab Sales Growth Rate (2014-2019)
Figure Boehringer Ingelheim Adalimumab Revenue Share in International Market (2014-2019)
Figure Boehringer Ingelheim Adalimumab Main Business and Markets Served
Table Mylan Adalimumab Production Sites and Area Served
Table Mylan Adalimumab Specification and Application
Table Mylan Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Mylan Adalimumab Sales Growth Rate (2014-2019)
Figure Mylan Adalimumab Revenue Share in International Market (2014-2019)
Figure Mylan Adalimumab Main Business and Markets Served
Table Biogen Adalimumab Production Sites and Area Served
Table Biogen Adalimumab Specification and Application
Table Biogen Adalimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Biogen Adalimumab Sales Growth Rate (2014-2019)
Figure Biogen Adalimumab Revenue Share in International Market (2014-2019)
Figure Biogen Adalimumab Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab
Figure Manufacturing Process Analysis of Adalimumab
Figure Adalimumab Industrial Chain Analysis
Table Adalimumab Distributors List
Table Adalimumab Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Adalimumab Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Adalimumab Price (USD/Unit) and Trend Forecast (2019-2025)
Table Global Adalimumab Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Adalimumab Sales Market Share Forecast by Regions (2019-2025)
Figure Global Adalimumab Sales Market Share Forecast by Regions in 2025
Table Global Adalimumab Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Adalimumab Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Adalimumab Revenue Market Share Forecast by Regions in 2025
Figure United States Adalimumab Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure United States Adalimumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Adalimumab Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Adalimumab Revenue and Growth Rate Forecast (2019-2025)
Figure China Adalimumab Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Adalimumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Adalimumab Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Adalimumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Adalimumab Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Adalimumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Adalimumab Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Adalimumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Adalimumab Sales (K Units) Forecast by Type (2019-2025)
Figure Global Adalimumab Sales Market Share Forecast by Type (2019-2025)
Table Global Adalimumab Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Adalimumab Revenue Market Share Forecast by Type (2019-2025)
Table Global Adalimumab Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Adalimumab Sales (K Units) Forecast by Application (2019-2025)
Figure Global Adalimumab Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



• 英文レポート名:Global Adalimumab Sales Market Report 2019
• 日本語訳:世界のアダリムマブ市場2019
• レポートコード:QYR9M0073お問い合わせ(見積依頼・ご注文・質問)